Ion Pacific is a private equity firm based in Hong Kong, established in 2015. The firm specializes in early-stage investments in the technology sector worldwide. It operates through two main entities: Ion Pacific Inc., registered as an Investment Advisor with the US SEC, and Ion Pacific Ltd., licensed by the Securities and Futures Commission in Hong Kong. The company provides a variety of investment services, particularly through its structured secondaries approach. This method allows investors to access venture-stage opportunities while offering downside protection and potential for significant returns. Ion Pacific's investment strategies include the Stonecutter series, which focuses on global venture capital, the Pathway fund targeting healthcare and life sciences, and a fund dedicated to Southeast Asia launched in 2022. The leadership team includes co-founders Itamar Har-Even and Ady Adefris, along with Antoine Autain and Jeff Sheran, who manage investor relations in different regions.